TREM2, whose neuro-protective function has been validated by genetic studies in Alzheimer’s disease and Nasu-Hakola disease, was significantly promoted by DEX in the microglia. This evidence concerns the gene TREM2 and early-onset autosomal dominant Alzheimer disease.